Posted on

Female Genital Tract Tissue Arrays

Please send your request for detailed information and quote to: info@vitrovivo.com

SKU#

DESCRIPTION

CASE

CORE

PRICE ($)

UT1001Endometrial cancer tissue array for antibody screening, including pathology grade, TNM and clinical stage, 25 cases/100 cores25100331.50
UT501bEndometrioid carcinoma tissue array with normal tissue, including pathology grade, TNM and clinical stage, 50 cases/50 cores, replacing UT501a5050253.50
T095Endometrium cancer test tissue array (4x (2×3)array), including TNM, clinical stage and pathology grade, 6 cases/24 cores62445.50
T094-1Endometrium cancer test tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 12cases/ 24cores, replacing T092122471.50
EM1021b(EM1021a)Endometrium cancer with endometrium tissue array, including pathology grade, TNM and clinical stage, 102 cases/102 cores, replacing EM1021a102102331.50
UT243Endometrium cancer with matched cancer adjacent endometrium tissue array, including pathology grade, TNM and clinical stage, 12 cases/24 cores, replaced by UT243a122471.50
UT243bEndometrium cancer with matched cancer adjacent endometrium tissue array, including pathology grade, TNM and clinical stage, 12 cases/24 cores, replaced UT243a122471.50
UT240Endometrium cancer, endometrium hyperplasia tissue array with adjacent tissue as control, including pathology grade, TNM and clinical stage, 24 cases/24 cores242484.50
UTN801a(UTN801)Endometrium tissue and endometrium cancer tissue array, including pathology grade, TNM and clinicla stage, 79 cases/80 cores, replacing UTN8017980448.50
CR2083Cervix cancer and adjacent normal survey tissue array (1 of 5), including pathology grade, TNM and clinical stage, 104 cases/208 cores104208513.50
CR485Cervix cancer and adjacent normal tissue array, including pathology grade, TNM and clinical stage, 48 cases/48 cores4848331.50
CR2088Cervix cancer survey tissue array (1 of 2), with normal tissue, including TNM and pathology grade, 208 cases/208 cores208208591.50
CR2089Cervix cancer survey tissue array (2 of 2), including TNM and pathology grade, 208 cases/208 cores208208591.50
CR2085Cervix cancer survey tissue array, including pathology grade, TNM, clinical stage, 104 cases/208 cores104208513.50
CC10-02-002Cervix cancer tissue array with adjacent normal and cancer adjacent tissue, including pathology grade, TNM and clinical stage, 63 cases/63 cores6363292.50
CR501b(CR501a)Cervix cancer tissue array with cancer adjacent tissue, including pathology grade, TNM and clinical stage, 50 cases/50 cores, replacing CR501a5050253.50
CR245Cervix cancer tissue array with matched adjacent cervix tissue, including pathology grade, TNM and clinical stage, 12 cases/24 cores122484.50
T102aCervix cancer tissue array with normal tissue as control, including TNM, clinical stage and pathology grade, 12 cases/24 cores, replacing T102122471.50
T103aCervix cancer with adjacent normal cervix tissue array, including pathology grade, TNM and clinical stage, 12 cases/24 cores, replacing T10362452.00
CER502Cervix cancer with cervix tissue array (2014 WHO classification), including pathology grade, TNM and clinical stage (AJCC 7th edition), 43 cases/50 cores5050175.50
CR802bCervix cancer with cervix tissue array (2014 WHO classification), including pathology grade, TNM and clinical stage (AJCC 7th edition), 65 cases/80 cores, replacing CR802a6580292.50
CR245bCervix cancer with matched cancer adjacent cervix tissue array, including pathology grade, TNM and clinical stage, 12 cases/24 cores, replacing CR245a122484.50
CR243aCervix cancer with normal tissue array, including pathology grade, TNM and clinical stage, 24 cases/48 cores, replacing CR2432448182.00
CER501Cervix squamous cell carcinoma with cervix tissue array (2014 WHO classification), including pathology grade, TNM and clinical stage (AJCC 7th edition), 50 cases/50 cores5050175.50
CR2086Cervix tumor tissue array (4 of 5), including pathology grade, TNM and clinical stage, 104 cases/208 cores104208617.50
CR1921Middle-advanced stage cervix cancer tissue array, including pathology grade, TNM and clinical stage, 96 cases/192 cores96192513.50
CR1001aMultiple cervix cancer tissue array with cancer adjacent and adjacent normal tissue, including pathology grade, TNM and clinical stage, 50 cases/100 cores, replacing CR100150100292.50
CR244aUterine cervix cancer tissue array with adjacent normal tissue, including pathology grade, TNM and clinical stage, 12 cases/24 cores, replacing CR241122471.50
CR602bUterine cervix disease spectrum tissue array, including pathology grade, TNM and clinical stage, 60 cases/60 cores, replacing CR602a6060292.50
UT1501Uterus cancer tissue array, including TNM, clinical stage and pathology grade, 75 cases/150 cores75150279.50
UT803Uterus cancer with endometrium tissue array, including pathology grade, TNM and clinical satge, 40 cases/80 cores4080331.50
UT721Uterus cancer with normal tissue array, including pathology grade, TNM and clinical stage, 24 cases/72 cores2472331.50
T103Cervical cancer test tissue array, with normal tissue as control, including TNM and pathology grade, 6 cases/24 cores, replaced by T103a62452.00
T104Cervical cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases/24 cores62452.00
CR246Cervix adenocarcinoma with cervix tissue array (2014 WHO classification), including pathology grade, TNM and clinical stage , 22 cases/24 cores2224182.00
OV603aOvarian serous cystadenoma tissue array with normal tissue as control, 30 cases/60 cores, replacing OV6033060292.50
OV482Multiple ovarian cancer tissue array with normal tissues, including pathology grade, 24 cases/48 cores2448214.50
OV8010Different stage of ovary cancer tissue array (1999 WHO classification) with metastasis carcinoma, including pathology diagnosis, TNM and clinical stage, 80 cases/80 cores8080331.50
OV8010bDifferent stage of ovary cancer tissue array (1999 WHO classification) with metastasis carcinoma, including pathology diagnosis, TNM and clinical stage, 80 cases/80 cores8080331.50
OV208aHigh density ovary cancer and ovary tissue array (1999 WHO classification), with metastatic adenocarcinoma, including pathology grade, TNM and clinical stage, 69 cases/207 cores, replacing OV20869207591.50
OV2001aHigh-density ovary cancer with adjacent normal ovary tissue array (1999 WHO classification), with metastatic carcinoma, including pathology grade, TNM and clinical stage, 200 cases/200 cores, replacing OV2001200200448.50
OV806Normal ovary tissue array, 30 cases/60 cores3060292.50
CR242Ovary cancer array with adjacent normal tissue, including pathology grade, 12 cases/24 cores122471.50
OV20810Ovary cancer survey tissue array (1 of 4), with normal tissue, including TNM and pathology grade, 208 cases/208 cores208208591.50
OV20811Ovary cancer tissue array (2 of 4), including TNM and pathology grade, 208 cases/208 cores208208591.50
OV20812Ovary cancer tissue array (3 of 4), including TNM and pathology grade, 208 cases/208 cores208208591.50
OV20813Ovary cancer tissue array (4 of 4), including TNM and pathology grade, 208 cases/208 cores208208591.50
OV701Ovary cancer tissue array and adjacent normal ovary tissue, including TNM, clinical stage and pathology grade, 70 cases/70 cores, replacing BC1111107070240.50
OV702aOvary cancer tissue array with adjacent normal tissue as control, including TNM and pathology grade, 70 cases/70 cores,replacing BC1111097070279.50
OV243Ovary cancer tissue array with normal tissue, including pathology grade, TNM and clinical stage, 2 serial sections, 24 cases/48 cores2448292.50
OV481Ovary cancer tissue array with unmatched adjacent normal tissue, including pathology grade, 24 cases/48 cores2448214.50
OV484Ovary cancer tissue array, including pathology grade, TNM and clinical stage, 48 cases/48 cores4848292.50
OV803cOvary cancer tissue array, including TNM and pathology grade, 80 cases/80 cores, replacing OV803b8080331.50
T114Ovary cancer tissue array, including TNM, clinical stage and pathology grade, 6 cases/24 cores62452.00
OV803bOvary cancer tissue array, including TNM, clinical stage and pathology grade, 80 cases/80 cores, replaced by OV8038080331.50
OVR502Ovary cancer with adjacent normal ovary tissue array (2014 WHO classification), including TNM and clinical satge (AJCC 7th edition), 50 cases/50 cores5050175.50
T111bOvary cancer with adjacent normal ovary tissue array, including pathology grade, TNM and clinical stage, 6 cases/24 cores, replacing T111a62471.50
OV801aOvary cancer with adjacent normal ovary tissue array, including pathology grade, TNM and clinical stage, 77 cases/80 cores, replacing OV8017780292.50
OV242aOvary cancer with adjacent normal ovary tissue array, including TNM and pathology grade, 12 cases/24 cores, replacing OV242122471.50
OV811Ovary cancer with normal tissue array (1999 WHO classification), including pathology grade, TNM and clinical stage, 40 cases/80 cores4080331.50
OV807aOvary cancer with ovary tissue array (2014 WHO classification), including patology grade, TNM and clinical stage (AJCC 7th edition), 40 cases/80 cores4080292.50
OVR501Ovary cancer with ovary tissue array (2014 WHO classification), including TNM and clinical satge (AJCC 7th edition), 50 cases/50 cores5050175.50
OV241cOvary cancer with ovary tissue array, including pathology grade, TNM and clinical stage, 12 cases/24 cores, replacing OV241b122471.50
OV809aOvary cancer with ovary tissue array, including pathology grade, TNM and clinical stage, 80 cases/80 cores, replacing OV8098080331.50
FOV-807aOvary cancer with ovary tissue array, including patology grade (2014 WHO classification), TNM and clinical stage (AJCC 7th edition), 40 cases/80 cores, replacing OV8074080292.50
OV483bOvary cancer with ovary tissue array, including TNM and clinical stage, 48 cases/48 cores, replacing OV483a4848214.50
T112cOvary cancer with overy tissue array, including pathology grade, TNM and clinical stage, 12 cases/ 24 cores, replacing T112b122452.00
OV1005cOvary disease spectrum (ovary cancer progression) tissue array (2014 WHO classification), including pathology grade, TNM and clinical stage, 100 cases/100 cores, replacing OV1005b100100292.50
OV1005dOvary disease spectrum (ovary cancer progression) tissue array (2014 WHO classification), including pathology grade, TNM and clinical stage, 100 cases/100 cores, replacing OV1005c100100292.50
OV602Ovary granulosa-theca cell tumor (malignant and benign) and cysts tissue array, 60 cases/60 cores6060292.50
OV804Ovary krukenberg tumor tissue array, 80 cases/80 cores8080279.50
OV805Ovary teratoma tissue array, 80 cases/80 cores8080292.50
OV2086Ovary tumor survey tissue array (2 of 5), including pathology grade, TNM and clinical stage, 104 cases/208 cores104208513.50
OV1002Ovary tumor tissue array, 100 cases/100 cores100100331.50
OV485Ovary tumor tissue array, including pathology grade, TNM and clinical stage, 2 serial sections, 48 cases/96 cores4896448.50
OV961Ovary tumor tissue array, including pathology grade, TNM and clinical stage, 48 cases/96 cores4896240.50
OV962Ovary tumor tissue array, including pathology grade, TNM and clinical stage, 48 cases/96 cores4896240.50
OV1501aOvary tumor tissue array, including TNM and pathology grade, 75 cases/150 cores, replacing OV150175150292.50
OV808bPeritoneum and omentum secondary tumor tissue array (all from ovary), including pathology grade, 40 cases/80 cores, replacing OV808a4080331.50
OV2084aOvary carcinoma tissue array with normal ovary tissue, including TNM, clinical stage and pathology grade, 208 cases/208 cores, replacing OV2084208208591.50
T471Uterine tube tumor with uterine tube tissue test array, including pathology grade, TNM and clinical stage, 6 cases/24 cores62471.50
UT801b(UT801a)External genitalia malignant tumor tissue array, including TNM, clinical stage and pathology grade, 39 cases/78 cores8080448.50
UV801External genitalia malignant tumor tissue array, including TNM, clinical stage and pathology grade, 39 cases/78 cores3978279.50
VUL501Vulva tumor and normal tissue array, including pathology grade, TNM and clinical stage, 50 cases/50 cores5050221.00
BE01017Different gestational age of fetal multiple organ normal tissue array, 10 cases/72 cores1072292.50
BE01018Fetal multiple organ normal tissue array, 14 cases/54 cores1454214.50
BE01016Fetal multiple organ normal tissue array, 4 cases/78 cores478214.50

TMA Applications:

Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH)

Notes:

1) TMA slides were sectioned and stored at 4°C and may not be fresh cut, but still suitable for IHC. Please request fresh cut if experiment involves phospho-specific antibodies, RNA studies, FISH or ISH, etc. A minimum of 3 slides per TMA must be purchased to cover the cost of trimming for fresh sectioning.
2. Most TMA slides were not coated with an extra layer of paraffin (tissue cores can be easily seen on the glass). To prevent tissue detachment during antigen retrieval, unbaked slides must be baked for at least 30 to 120 minutes at 60°C. before putting into xylene for de-paraffinization. Baked slides were sent out baked for 2 hours.

TNM Grading

T – Primary tumor
      Tx – Primary tumor cannot be assessed
      T0 – No evidence of primary tumor
      Tis – Carcinoma in situ; intraepithelial or invasion of lamina propria
      T1 – Tumor invades submucosa
      T2 – Tumor invades muscularis propria
      T3 – Tumor invades through muscularis propria into subserosa or into non-peritonealized pericolic or perirectal tissues.
      T4 – Tumor directly invades other organs or structures and/or perforate visceral peritoneum

N – Regional lymph nodes
     Nx – Regional lymph nodes cannot be assessed
     N0 – No regional lymph node metastasis
     N1 – Metastasis in 1 to 3 regional lymph nodes
     N2 – Metastasis in 4 or more regional lymph nodes

M – Distant metastasis
     Mx – Distant metastasis cannot be assessed
     M0 – No distant metastasis
     M1 – Distant metastasis

Stage of Cancer

  • Stage 0 means there’s no cancer, only abnormal cells with the potential to become cancer. This is also called carcinoma in situ.
  • Stage I means the cancer is small and only in one area. This is also called early-stage cancer.
  • Stage II and III mean the cancer is larger and has grown into nearby tissues or lymph nodes.
  • Stage IV means the cancer has spread to other parts of your body. It’s also called advanced or metastatic cancer.